Diagnosis

General overview of HIV/AIDS in the United States of America.

This document describes the steps necessary to implement the shorter regimen and the new drugs for drug-resistant TB treatment, including diagnosis and bacterial confirmation of drug resistance, treatment regimen design, monitoring of treatment efficacy and safety, and programmatic evaluation.

This guide provides an overview of TB diagnostic tools and suggests recommendations for how activists and clinicians can contribute to improved TB diagnosis.

This campaign creates a national storybank featuring real people living with hepatitis B who share their stories and put a human face on this serious disease. They hope to decrease stigma and discrimination and promote testing, immunization and treatment for hepatitis B to save lives. A new story will be featured each month during 2017. 

Online information providing survey results on the usage, shortage, and outcomes of Bicillin to treat syphilis.

This report describes an outbreak of drug-susceptible TB that occurred in a South Carolina state correctional facility housing HIV-infected inmates and illustrates the need for increased vigilance for TB in settings in which HIV-infected persons congregate.

This notice explains that on September 30, 1999, the Food and Drug Administration approved a reformulated amplified Mycobacterium Tuberculosis Direct (MTD) test for detection of Mycobacterium tuberculosis in acid-fast Bacille (AFB) smear-positive and smear-negative respiratory specimens from patients suspected of having TB.

The purpose of this flipbook is to assist healthcare workers in providing patient education around TB testing, TB infection and TB disease. Panels for patients include simple text and images to reinforce key messages and corresponding panels for providers include easy to deliver script and teaching points.

This fact sheet discusses the meaning of a negative TB skin test and states that persons with HIV/AIDS may be at risk for false negative results.

This framework identifies key issues that need to be addressed to accelerate the adoption and implementation of new and improved technologies. It provides guidance on what actions are needed when improved existing and/or new medicines, diagnostics and vaccines become available.

The document identifies challenges to retooling and proposes key steps for facilitating appropriate and timely adoption and implementation. It also provides an overview of technical and operational considerations for retooling at global and national levels.